🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Episodic Migraine

Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine NCT07496034Phase 31 site📍 Taichung Tsai, Chueh-Yi, MD · Tests: Gou-Teng-San, Placebo Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine NCT07159750n/a26 sites📍 Miami📍 Buenos Aires📍 Santiago Hospital Universitari Vall d'Hebron Research Institute · Tests: CGRP antibody or gepant Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine NCT07279623NA1 site📍 Stockholm Abilion Medical Systems AB · Tests: INMEST-treatment Trial Designs for Evaluating Migraine Treatment NCT06617832NA2 sites📍 Aarhus C📍 Aarhus N University of Aarhus · Tests: Active drug for acute migraine treatment, Placebo Oral Tablet Prophylactic Treatment With Atorvastatin for Episodic Migraine. NCT06248671Phase 26 sites📍 Bergen📍 Lørenskog📍 Oslo St. Olavs Hospital · Tests: Atorvastatin 40mg, Placebo, Atorvastatin 20mg Chiropractic Care for Episodic Migraine NCT06229834NA1 site📍 Boston Brigham and Women's Hospital · Tests: Chiropractic Care, Headache Health Education i-NEED: NEw migrainE Drugs Database NCT07103694n/a2 sites📍 Milan📍 Rome IRCCS San Raffaele Roma · Tests: anti-CGRP monoclonal antibodies, gepants, combination of sumatriptan and naproxen, ditan Treatment of Episodic Migraine With AURICular Neuromodulation NCT06623188NA3 sites📍 Marseille📍 Marseille📍 Marseille Hôpital Européen Marseille · Tests: Auricular neuromodulation, Sham auricular neuromodulation A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine NCT07719608NA3 sites📍 Newnan📍 Olney📍 Charlotte Salvia BioElectronics · Tests: Neurostimulator Idebenone for the Preventive Treatment of Migraine NCT04151472Phase 31 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Placebo, 90mg Idebenone, 270mg Idebenone Study of EVO756 in Adults With Migraine NCT07616128Phase 235 sites📍 Chandler📍 Buena Park📍 Fresno Evommune, Inc. · Tests: EVO756, Dose 1, EVO756, Dose 2, Placebo Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD NCT07348783NA1 site📍 Huddinge Karolinska Institutet · Tests: Intervention yoga based exercises Tai Chi and Acupuncture on Migraine Attack Prevention and Brain White Matter Changes NCT06967909NA1 site📍 Hung Hom The Hong Kong Polytechnic University · Tests: Tai Chi training, Acupuncture PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE NCT07268768n/a1 site📍 Messina IRCCS Centro Neurolesi Bonino Pulejo · Tests: Neuropsychological assessment Vitamin K2 Supplementation in Adult Episodic Migraine NCT05943457NA1 site📍 Beirut Sola Aoun Bahous, M.D. Ph.D. · Tests: Vitamin K2 or menaquinone-7, Placebo Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine NCT07694063NA1 site📍 Seville University of Seville · Tests: Control group (receiving standard medical therapy alone), Hatha yoga Cabergoline for Episodic Migraine NCT07072910Phase 21 site📍 Aarhus N Aarhus University Hospital · Tests: Cabergoline 0.5 MG, Placebo, Cabergoline 1 MG Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification NCT06674772n/a1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Saliva test The RECLAIM Study. NCT06450444NA11 sites📍 Broadmeadow📍 Buderim📍 Wilrijk Salvia BioElectronics · Tests: PRIMUS EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine. NCT05570149n/a1 site📍 Roma IRCCS San Raffaele Roma · Tests: Eptinezumab 100 mg or Eptinezumab 300 mg administered intravenously in 100 mL saline solution A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine NCT05164172Phase 364 sites📍 New Haven📍 Stamford📍 Gainesville H. Lundbeck A/S · Tests: Eptinezumab Efficacy of Nerve Blocks for Episodic Migraine NCT05734625Phase 21 site📍 Rochester Mayo Clinic · Tests: Bupivacaine HCl 0.5% Injectable Solution, Methylprednisolone 40 MG Injection A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine NCT06602479Phase 254 sites📍 Birmingham📍 Huntsville📍 La Jolla AbbVie · Tests: MEDI0618, Placebo Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine NCT06603558n/a36 sites📍 Busan📍 Busan📍 Busan AbbVie · Tests: Atogepant Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine NCT06882122n/a1 site📍 Pavia IRCCS National Neurological Institute "C. Mondino" Foundati… · Tests: Atogepant 60 mg High-Density EEG-MEG-wearable EEG: Comparison of Quantitative Electroencephalographic Indicators as Neurophysiological Markers of Effectiveness of Mindfulness Therapy in Addition to Standard Treatment in Patients With High-frequency Episodic Migraine NCT06938178n/a1 site📍 Milan Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Tests: Mindfulness treatment CGRP Inhibition, Autonomic Function, and Migraine NCT04628429n/a1 site📍 Vienna Medical University of Vienna · Tests: Erenumab, Galcanezumab, Fremanezumab A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine NCT05711394Phase 398 sites📍 Huntsville📍 Saraland📍 Little Rock AbbVie · Tests: Atogepant, Placebo-Matching Atogepant Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes NCT07518069n/a1 site📍 Milan IRCCS San Raffaele · Tests: a blood withdrawal will be obtained, blood withdrawal A Study of Eptinezumab in Pediatric Participants With Episodic Migraine NCT05897320Phase 360 sites📍 Stamford📍 Gulf Breeze📍 Hialeah H. Lundbeck A/S · Tests: Eptinezumab, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy